Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents
Chemical Biology & Drug Design · 2023-12 · 102 (6) · 1643-1657
DOI: 10.1111/cbdd.14347 ↗At a glance
Übersichtsarbeit in Chemical Biology & Drug Design, published online on 2023-09-13. Written by Yili Dai and 10 co-authors. Institution: Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China. Major MEDLINE topics: Triterpenes. Cited 9 times so far (Crossref); 39 references.
Topics: Diabetes mellitus
Abstract (original language)
Ursolic acid (UA) is a pentacyclic triterpenoid, which exhibits many biological activities, particularly in anti‐cardiovascular and anti‐diabetes. The further application of UA is greatly limited due to its low bioavailability and poor water solubility. Up to date, various UA derivatives have been designed to overcome these shortcomings. In this paper, the authors reviewed the development of UA derivatives as the anti‐diabetes anti‐cardiovascular reagents.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China.
- Department of Pharmacy, Hunan Vocational College of Science and Technology, Changsha, China.
ORCID profiles: Yili Dai
Cite
APA
Dai, Y., Sun, L., Tan, Y., Xu, W., Liu, S., Zhou, J., Hu, Y., Lin, J., Yao, X., Mi, P., & Zheng, X. (2023). Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents. Chemical Biology & Drug Design, 102(6), 1643-1657. https://doi.org/10.1111/cbdd.14347
Vancouver
Dai Y, Sun L, Tan Y, Xu W, Liu S, Zhou J, et al. Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents. Chemical Biology & Drug Design. 2023;102(6):1643-1657. doi:10.1111/cbdd.14347
BibTeX
@article{Dai2023,
author = {Dai, Yili and Sun, Linjun and Tan, Yan and Xu, Wenyu and Liu, Shu and Zhou, Jing and Hu, Yalin and Lin, Jieying and Yao, Xu and Mi, Pengbing and Zheng, Xing},
title = {Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents},
journal = {Chemical Biology & Drug Design},
year = {2023},
volume = {102},
number = {6},
pages = {1643--1657},
doi = {10.1111/cbdd.14347}
}
EUVIMED